Comments
Loading...

PainReform

PRFXNASDAQ
Logo brought to you by Benzinga Data
$0.780100
-0.05-6.01%
Last update: 9:17 AM
15 minutes delayed

PainReform (NASDAQ:PRFX) Stock Quotes, Forecast and News Summary

PainReform Stock (NASDAQ: PRFX) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.65.82K / 360.35K
Day Range- - -
52 Wk Range0.72 - 23.88
Market Cap$913.53K
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
28
Short Interest
1.53%
Days to Cover1

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
0
0
0
0
Jun
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulat...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
PRFX

FAQ

Q

How do I buy PainReform (PRFX) stock?

A

You can purchase shares of PainReform (NASDAQ:PRFX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are PainReform (PRFX) competitors?

A

There are no as such competitors for PainReform.

Q

What is the forecast, or price target, for PainReform (PRFX) stock?

A

PainReform has a consensus price target of $2.00.

Q

What is the current price for PainReform (PRFX)?

A

The stock price for PainReform (NASDAQ: PRFX) is $0.7801 last updated September 19, 2024 at 9:17 AM EDT.

Q

Does PainReform (PRFX) pay a dividend?

A

There are no upcoming dividends for PainReform.

Q

When is PainReform (NASDAQ:PRFX) reporting earnings?

A

PainReform’s Q3 earnings are confirmed for Wednesday, November 13, 2024.

Q

Is PainReform (PRFX) going to split?

A

There is no upcoming split for PainReform.

Q

What sector and industry does PainReform (PRFX) operate in?

A

PainReform is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.